89Zr-Df-IAB22M2C PET/CT in Patients With Selected, Metastatic Solid Malignancies or Hodgkin's Lymphoma

Conditions:   Positron-Emission Tomography;   Immunomodulation;   Metastatic Solid Malignancies;   Hodgkin Lymphoma
Intervention:   Drug: 89Zr-Df-IAB22M2C Infusion
Sponsor:   ImaginAb, Inc.
Recruiting - verified August 2017

http://ift.tt/2hrtgSu